JAC Advance Access published online on February 12, 2004
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkh118
© 2004 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Original article
1 Division of Infectious
Diseases, Samsung Medical Center, Sungkyunkwan University
School of Medicine, 50 Il-won dong, Kangnam-ku, Seoul 135-710;
* Corresponding author. E-mail: jhsong{at}ansorp.org.
Received 15 August 2003
; revised 17 December 2003
; accepted 17 December 2003
Objectives: To characterize mechanisms
of macrolide resistance among Streptococcus pneumoniae from 10
Asian countries during 1998-2001. Methods: Phenotypic and genotypic characterization
of the isolates and their resistance mechanisms. Results: Of 555 isolates studied, 216 (38.9%)
were susceptible, 10 (1.8%) were intermediate and 329 (59.3%) were
resistant to erythromycin. Vietnam had the highest prevalence of
erythromycin resistance (88.3%), followed by Taiwan (87.2%),
Korea (85.1%), Hong Kong (76.5%) and China (75.6%).
Ribosomal methylation encoded by erm(B) was the
most common mechanism of erythromycin resistance in China, Taiwan,
Sri Lanka and Korea. In Hong Kong, Singapore,
Thailand and Malaysia, efflux encoded by mef(A)
was the more common in erythromycin-resistant isolates. In most
Asian countries except Hong Kong, Malaysia and Singapore, erm(B)
was found in >50% of pneumococcal isolates either
alone or in combination with mef(A). The level
of erythromycin resistance among pneumococcal isolates in most Asian
countries except Thailand and India was very high with MIC90s
of >128 mg/L. Molecular epidemiological studies suggest
the horizontal transfer of the erm(B) gene and
clonal dissemination of resistant strains in the Asian region. Conclusion: Data confirm that macrolide resistance
in pneumococci is a serious problem in many Asian countries.
Keywords: erythromycin, erm(B), mef(A),
pneumococci
Macrolide resistance and genotypic characterization
of
Streptococcus pneumoniae in Asian countries: a study of the
Asian Network for Surveillance of Resistant Pathogens (ANSORP)
2 Department of Medicine, Kyunghee University
Medical Center, Seoul;
3 Asian-Pacific
Research Foundation for Infectious Diseases (ARFID), Seoul;
4 Chonnam National University Hospital,
Kwangju, Korea;
5 Division of Infectious
Diseases, Samsung Medical Center, Sungkyunkwan University
School of Medicine, 50 Il-won dong, Kangnam-ku, Seoul 135-710;
6 Department
of Laboratory Medicine, Samsung Medical Center, Sungkyunkwan University
School of Medicine, 50 Il-won dong, Kangnam-ku, Seoul 135-710;
7 Beijing
Children’s Hospital, Beijing, China;
8 Chulalongkorn University, Bangkok;
9 Siriraj Hospital, Bangkok, Thailand;
10 Chang Gung Children’s
Hospital, Taipei, Taiwan;
11 Christian
Medical College, Vellore, India;
12 University of Colombo, Colombo, Sri Lanka;
13 National University of Singapore,
Singapore;
14 Universiti Putra
Malaysia, Kuala Lumpur;
15 University
Malaya, Kuala Lumpur, Malaysia;
16 University
of Medicine and Pharmacy, Ho Chi Minh City, Vietnam;
17 Princess Margaret Hospital, Hong
Kong
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Del Grosso, J. G. E. Northwood, D. J. Farrell, and A. Pantosti The Macrolide Resistance Genes erm(B) and mef(E) Are Carried by Tn2010 in Dual-Gene Streptococcus pneumoniae Isolates Belonging to Clonal Complex CC271 Antimicrob. Agents Chemother., November 1, 2007; 51(11): 4184 - 4186. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rahman, S. Hossain, S. Shoma, H. Rashid, A. H. Baqui, M. van der Linden, A. Al-Lahham, and R. R. Reinert Emergence of a Unique Multiply-Antibiotic-Resistant Streptococcus pneumoniae Serotype 7B Clone in Dhaka, Bangladesh J. Clin. Microbiol., December 1, 2006; 44(12): 4625 - 4627. [Full Text] [PDF] |
||||
![]() |
J.-H. Song, S.-I. Jung, K. S. Ko, N. Y. Kim, J. S. Son, H.-H. Chang, H. K. Ki, W. S. Oh, J. Y. Suh, K. R. Peck, et al. High Prevalence of Antimicrobial Resistance among Clinical Streptococcus pneumoniae Isolates in Asia (an ANSORP Study) Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2101 - 2107. [Abstract] [Full Text] [PDF] |
||||

